West Pharmaceutical Services Inc (NYSE:WST) under-valued by 17%
| Website | https://www.westpharma.com/ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $24,056,928,256 |
| Beta | 0.953667 |
| Average Volume | $408,545 |
| Last Dividend | 0.67% |
| Price on Oct 27, 2022 | $221.23 |
| Autochartist™ Valuation | $258.36 |
| Conclusion |
17% under-valued |
| Download Report |
